These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 8174799

  • 1. Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivatives by pasteurisation.
    Nowak T, Niedrig M, Bernhardt D, Hilfenhaus J.
    Dev Biol Stand; 1993; 81():169-76. PubMed ID: 8174799
    [Abstract] [Full Text] [Related]

  • 2. Viral safety of solvent-detergent treated blood products.
    Horowitz B, Prince AM, Horowitz MS, Watklevicz C.
    Dev Biol Stand; 1993; 81():147-61. PubMed ID: 8174797
    [Abstract] [Full Text] [Related]

  • 3. Theoretical and technical concerns in inactivation/elimination of viruses in plasma derivatives.
    Hilfenhaus J, Niedrig M, Nowak T.
    Dev Biol Stand; 1993; 81():117-23. PubMed ID: 8174794
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
    Ristol P, Gensana M, Fernández J, Massot M, Biescas H, Darling A, Jorquera JI, Vericat F.
    Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
    [Abstract] [Full Text] [Related]

  • 5. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
    Kim IS, Choi YW, Kang Y, Sung HM, Shin JS.
    J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Assessment of needs for plasma for fractionation in Europe.
    Burckhardt JJ.
    Biologicals; 1999 Dec; 27(4):337-41. PubMed ID: 10686061
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inactivation of HTLV-III/LAV, hepatitis B and non-A/non-B viruses by pasteurization in human plasma protein preparations.
    Mauler R, Merkle W, Hilfenhaus J.
    Dev Biol Stand; 1987 Dec; 67():337-51. PubMed ID: 3111911
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Resistance of porcine circovirus and chicken anemia virus to virus inactivation procedures used for blood products.
    Welch J, Bienek C, Gomperts E, Simmonds P.
    Transfusion; 2006 Nov; 46(11):1951-8. PubMed ID: 17076851
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.